Table 3 Initial antimicrobial management of P. aeruginosa SSI
Empirical | (n = 45, 72.5%) | Targeted | (n = 7, 11.3%) |
|---|---|---|---|
Antibiotic | n (%) | Antibiotic | n (%) |
Amoxicillin-clavulanic acid | 15 (33.3) | Piperacillin-tazobactam | 2 (28.5) |
Meropenem/Imipenem | 13 (28.8) | Meropenem | 1 (14.2) |
Piperacillin-tazobactam | 9 (20) | 3GC plus metronidazole | 1 (14.2) |
3GC | 2 (4.4) | FQ | 1 (14.2) |
FQ plus metronidazole | 2 (4.4) | 3GC | 1 (14.2) |
Aminoglycoside plus metronidazole | 1 (2.2) | FQ plus metronidazole | 1 (14.2) |
3GC plus metronidazole | 1 (2.2) | ||
Piperacillin-tazobactam plus cotrimoxazole | 1 (2.2) | ||
Antifungal | |||
Fluconazole | 1 (2.2) | ||